Robert Belshe, M.D.
Dr. Belshe, the Dianna and J. Joseph Adorjan Endowed Professor of Infectious Diseases and Immunology at Saint Louis University School of Medicine, is one of the foremost vaccine researchers in the country. He has been the overall Principal Investigator of the Saint Louis University Vaccine and Treatment Evaluation Unit (VTEU) since coming to Saint Louis University in 1989. He currently serves on the National Advisory Allergy and Infectious Diseases (NAAID) Council, advising the National Institute of Allergy and Infectious Diseases on long-term planning and broad research priorities.
An expert in designing and executing clinical trials, Belshe has conducted extensive research on the antibody responses to viral vaccines for diseases including influenza, genital herpes and smallpox. His findings have been published in the New England Journal of Medicine, JAMA, The Lancet and PNAS, among other peer-reviewed medical journals.